SCHEMBL6171365

SCHEMBL6171365

CCOC(=O)C(C)C(SC(C)=O)C(=O)OCC

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 8/20 0.39
LMNA P02545 2/20 0.39
HSD17B10 Q99714 2/20 0.39
ALOX15 P16050 3/20 0.33
HPGD P15428 2/20 0.33
MGAM O43451 1/20 0.33
GAA P10253 1/20 0.33
SI P14410 1/20 0.33
MGAM2 Q2M2H8 1/20 0.33
SOAT1 P35610 1/20 0.33
KMT2A Q03164 2/20 0.32
MAPT P10636 1/20 0.32
RAB9A P51151 1/20 0.32
NPSR1 Q6W5P4 1/20 0.32
GLO1 Q04760 1/20 0.31
TRPA1 O75762 1/20 0.31
CYP3A4 P08684 2/20 0.31
CYP2D6 P10635 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL819540 0.82 ALDH1A1 (0.41) ALDH1A1LMNAHSD17B10ALOX15HPGD
SCHEMBL18113151 0.77 ALDH1A1 (0.44) ALDH1A1LMNAHSD17B10ALOX15HPGD
SCHEMBL11063755 0.77 ALDH1A1 (0.44) ALDH1A1LMNAHSD17B10ALOX15HPGD
SCHEMBL19318891 0.75 ALDH1A1 (0.53) ALDH1A1LMNAHSD17B10ALOX15HPGD
SCHEMBL12640198 0.75 ALDH1A1 (0.53) ALDH1A1LMNAHSD17B10ALOX15HPGD
SCHEMBL765721 0.71 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10ALOX15HPGD
SCHEMBL15034672 0.71 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10ALOX15HPGD
SCHEMBL12328387 0.71 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10ALOX15HPGD
SCHEMBL764895 0.71 ALDH1A1 (0.48) ALDH1A1LMNAHSD17B10ALOX15HPGD
SCHEMBL10761082 0.71 ALDH1A1 (0.38) ALDH1A1LMNAHSD17B10ALOX15HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6953789-B2 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2005-10-11 US disclosed
US-20040157894-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-08-12 US disclosed
US-6699881-B2 MATRIX METALLOPROTEASE INHIBITORS TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2004-03-02 US disclosed
US-20030078253-A1 Thiol compounds, their production and use TAKEDA PHARMACEUTICAL COMPANY, LIMITED (JP) 2003-04-24 US disclosed
US-6420415-B1 Thiol compounds, their production and use TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) 2002-07-16 US disclosed
EP-1132379-A1 NOVEL THIOL DERIVATIVES, PROCESS FOR PRODUCING THE SAME AND UTILIZATION THEREOF Takeda Chemical Industries, Ltd. (JP) 2001-09-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030078253-A1 Thiol compounds, their production and use TST, QSOX1, SULT1E1 ALDH1A1 905/4885LMNA 4373/4885HSD17B10 520/4885
US-20040157894-A1 Thiol compounds, their production and use TST, SULT1E1, QSOX1 ALDH1A1 877/4885LMNA 4464/4885HSD17B10 403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.